MINI FUTURE SHORT - ABBVIE Share Price

Certificat

DE000MG00Z58

Market Closed - Bid/Ask 12:27:32 29/05/2024 am IST
5.92 EUR +4.41% Intraday chart for MINI FUTURE SHORT - ABBVIE
Current month+7.39%
1 month+1.98%
Date Price Change
29/24/29 5.92 +4.41%
27/24/27 5.67 -0.87%
24/24/24 5.72 +2.69%
23/24/23 5.57 +1.46%
22/24/22 5.49 +7.23%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 12:27 am IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying ABBVIE INC.
Issuer Morgan Stanley
WKN MG00Z5
ISINDE000MG00Z58
Date issued 11/03/2024
Strike 218.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.66
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.92
Lowest since issue 3.44
Spread 0.01
Spread %0.17%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
157.1 USD
Average target price
182.3 USD
Spread / Average Target
+16.05%
Consensus